CinRx Pharma Announces Gavin Samuels as Chief Business Officer
![](https://cinrx.com/wp-content/uploads/2022/10/web-tile-500x200-1.png)
CinRx Pharma announced today that Gavin Samuels, M.D., M.B.A has assumed the role of Chief Business Officer.
CinRx Pharma Announces First Study for the Treatment of Obesity
![](https://cinrx.com/wp-content/uploads/2022/09/cinfina-tile.jpg)
CinRx Pharma announced the first study participant has been dosed in CinFina’s Phase 1 multiple ascending dose (MAD) study of CIN-109.
vTv Therapeutics Announces Investment by CinRx Pharma
![](https://cinrx.com/wp-content/uploads/2022/08/vtv-tile-1.jpg)
vTv Therapeutics Inc. today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a subsidiary of CinRx Pharma, LLC (“CinRx”).